Introduction
Necrotic enteritis (NE) is a common disease in broiler chickens caused predominantly by Clostridium perfringens (Songer, 1996) . Usually, NE occurs 2-6 weeks after hatching and is characterized by the sudden onset of diarrhea and mucosal necrosis caused by overgrowth of C. perfringens in the small intestine (Ficken and Wages, 1997; Fukata et al., 1991) . The mere presence of C. perfringens does not necessarily lead to disease but at a critical population size, toxin production results in necrotization of the gastrointestinal epithelium from random foci (Cowen et al., 1987; Engberg et al., 2002; Ficken and Wages, 1997; Pedersen et al., 2003) . The mechanisms behind establishment of infection are not fully determined and several new virulence factors and mechanisms have been suggested recently (Keyburn et al., 2008; Kulkarni et al., 2008; Olkowski et al., 2008) . The a-toxin (phospholipase C) is however believed to play an important role in the severity of the disease (AlSheikhly and Truscott, 1977a, 1977b; Awad et al., 1995; Fukata et al., 1988; Thompson et al., 2006; Williamson and Titball, 1993) and immunization with recombinant a-toxin has been shown partly to protect broilers in experimental challenges with C. perfringens (Cooper et al., 2009; Kulkarni et al., 2007) . The dynamics of a-toxin production during growth of different C. perfringens strains are poorly understood. The goal of this study was therefore to investigate the relationship between growth phase, plc gene transcription, and a-toxin production in three C. perfringens strains representing low, intermediate and high levels of a-toxin production, respectively.
Materials and methods

Bacterial strains and growth conditions
In previous studies, 60 strains of C. perfringens with different pulsed-field gel electrophoresis profiles were isolated from chickens, analyzed for their a-toxin sequence type (Abildgaard et al., 2009; Pedersen et al., 2003) and 35 isolates were further screened for production of a-toxin in batch cultures (Abildgaard et al., 2009) similar to the approach used by Gholamiandekhordi et al. (2006) . Based on this screening, the following three strains were selected for more detailed studies: (i) strain T2 (sequence type: VIe (Abildgaard et al., 2009) ; source: NE chicken; a-toxin production level: low, <1% of maximum detected a-toxin production (MDAP) of the 35 strains); (ii) strain S3 (sequence type: Vb; source: healthy chicken; atoxin production level: intermediate, 57% of MDAP of the 35 strains); and (iii) strain T9 (sequence type: Vb; source: NE chicken; a-toxin production level: high, 85% of MDAP of the 35 strains). The strains were maintained in Anaerobe Basal Broth (CM0957; Oxoid Ltd., Basingstoke, Hampshire, UK) at 30 8C; 500-ml infusion bottles with 400 ml broth were inoculated (0.1%) from overnight cultures, flushed (80% N 2 , 10% CO 2 , and 10% H 2 ) and incubated at 37 8C under agitation (120 rpm) to avoid aggregation and subcultures in different growth phases. At regular intervals, growth was measured as OD 600 , and samples were withdrawn for quantification of plc mRNA by reverse transcriptase quantitative PCR (RT-qPCR; see below) and of a-toxin by the ELISA method previously described (Abildgaard et al., 2009) . All experiments were performed in triplicates. The three selected strains were further analyzed for their a-toxin production pattern (a-toxin accumulation in overnight batch cultures) to check for potential inter-strain differences in intracellular pools and/ or differences in protease degradation of the a-toxin. For this purpose, batch cultures of the strains were inoculated (0.1%) from pre-cultures as outlined above and grown overnight (approximately 16 h) at 37 8C in 10 ml anaerobe basal broth. The suspensions were centrifuged and the supernatants and the pellets were immediately frozen separately in liquid nitrogen and stored at À80 8C. The frozen pellets were re-suspended in 1 ml TES buffer (define) and 500 ml was transferred to Eppendorf tubes containing 200 mg glass beads (0.18 mm) and amended with 5 ml 100Â Protease Inhibitor Cocktail Set I (539131, CALBIOCHEM 1 , San Diego, CA). The suspensions were Vortexed (1 min), 5 ml lysozyme (10 mg ml À1 ) added and the tubes were incubated 30 min at 37 8C. The tubes were Vortexed (1 min) again, centrifuged and the supernatants were frozen in liquid nitrogen and stored at À80 8C. The supernatants from the overnight cultures as well as from the lysed cells were analyzed for a-toxin content by the previously described ELISA method (Abildgaard et al., 2009) , where the former were amended with the protease inhibitor as well prior to the analysis.
TaqMan probes and primers
Published primers and probes for qPCR (Skå nseng et al., 2006) showed several mismatches to the recently extended plc gene sequence set (Abildgaard et al., 2009 ). To exclude target underestimation caused by destabilizing mismatches (Werbrouck et al., 2007) , a new primer/probe set (Table 1 ) was designed using the Primer Express software package (v. 2.0; Applied Biosystems, Stockholm, Sweden), and checked for potential cross-reactivity against the GenBank database (http://www.ncbi.nlm.nih.gov). Positions 339-340 were avoided as target sites, since an intron between these positions had been observed in strain S3 and other strains of C. perfringens (Abildgaard et al., 2009; Ma et al., 2007) . Two constitutively expressed genes were selected for normalization of plc transcript levels: gyrA, encoding DNA gyrase (Huang, 1996) , and rplL, encoding the ribosomal protein L7/L12 (Ramakrishnan and Moore, 2001) . Sequences for gyrA and rplL were retrieved from 24 C. perfringens strains (GenBank accession numbers: EU834132-EU834179) isolated from chickens using published primers (Rooney et al., 2006) , and were used, together with 124 gyrA and 244 rplL sequences of C. perfringens isolated from various sources (Rooney et al., 2006) , for probe and primer design (Table 1) .
Quantitative real-time RT-PCR amplification
Samples of RNA from strains S3, T2, and T9 were preserved by transferring aliquots of 0.5 ml culture to 2 ml microcentrifuge tubes containing 1 ml RNA protect (QIA-GEN). Total RNA was isolated using the RNAprotect protocol (QIAGEN) which includes enzymatic lysis, proteinase K digestion, and mechanical disruption, and purified using the RNeasy mini kit (QIAGEN) according to the manufacturer's recommendations. The RNA was eluted twice in 20 ml RNase free water. The QIAGEN RNaseFree DNase Set was applied during RNA extraction to remove DNA. The concentration and purity of the RNA was determined as absorbance at 260 and 280 nm in a NanoDrop ND-1000 Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). The RNA was stored at À80 8C for a maximum of 1 week before cDNA synthesis to minimize differential RNA degradation reported for longer storage (Alifano et al., 1994; Rudi et al., 2003) . Reverse transcription (RT) was performed using the first-strand cDNA protocol and SuperScriptTMIII reverse transcriptase (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's recommended protocol with 100 ng RNA and 100 ng random hexamer primers (Invitrogen) per reaction. The thermal profile was as follows: 25 8C for 5 min, 50 8C for 60 min, and 70 8C for 15 min. The resulting cDNA (1 ml in a total of 10 ml reaction volume) was amplified with TaqMan Universal PCR Master Mix (Applied Biosystems, Stockholm, Sweden) with 0.4 mg ml À1 bovine serum 398F  CTA GAT ATG AAT GGC AAA GAG GAA ACT A  475R  AAC ATT GCA GGA TGA TAT GGA GTA GTA TCT AT  430T  CAA GCT ACA TTC TAT CTT GGA GAG GCT  ATG CAC TAT TT   RplL  3F  GAC AAA AGA GCA AAT CAT AGA AGC TAT AA  125R  TCC GCC TAC AAC AGC AAC TG  69T  TGT GAA GAA GAA TTC GGA TTC GGA GTA  AGC GCT GC   GyrA  693F  CAT TAA AGG ACC AGA TTT CCC TAC AG  771R  TTT TCC AGT TTC ATA AGC AGC TCT T  720T AGG AAT AAT AAT GGG TAA ATC AGG AA albumin (Fermentas, Helsingborg, Sweden) and 0.5 pmol ml À1 primers and 0.1 pmol ml À1 probe (Table 1) . The probes contained 6-carboxyfluorescein (FAM) at the 5 0 end and either 6-carboxytetramethylrhodamine (TAMRA) (plc and rplL) or a non-fluorescent quencher with the MGB protein (Applied Biosystems) at the 3 0 end (gyrA). A 7900HT sequence detection system (Applied Biosystems) was used for qPCR with the following temperature settings: 2 min start up at 50 8C, 10 min initial denaturation at 95 8C, and 40 cycles of denaturing at 95 8C (15 s) and annealing/extension at 60 8C (1 min). Data were analyzed with the SDS 2.1 application software (Applied Biosystems). A standard curve (7 Â 10 5 to 70 genomes ml À1 ) was prepared by serial dilution of C. perfringens genomic DNA of known concentration, using the genome size of C. perfringens strain 13 and Avogadro's number for calculations. Since plc, gyrA, and rplL are single copy genes in C. perfringens (Shimizu et al., 2002) , cycle thresholds (C T values) were directly converted to gene copy numbers for the standards; results are expressed as number of plc transcripts relative to gyrA or rplL transcript numbers.
Results
Levels of a-toxin production
The relative levels of extra cellular a-toxin accumulation in batch cultures of the three strains (T9: high; S3: intermediate; and T2: low/insignificant) as illustrated in Fig. 1D were highly reproducible and could be repeated with months interval (data not shown). In a control experiment it was further observed that the intracellular pools of a-toxin were insignificant. Thus, a-toxin could only be detected in lysate from the high producing strain T9 and at a concentration 500Â lower than in the supernatant. The samples, taken from the control experiments, were all amended with protease inhibitor during the analysis to avoid any bias caused by differences in atoxin degradation between the strains.
Design of RT-real-time PCR protocol
While all primers had a perfect match to their target site, the large gyrA sequence variation caused problems for designing a suitable probe: despite the design as minor groove-binding (MGB) probe, which forms an extremely stable duplex with single-stranded DNA and therefore allows shorter probe lengths (Kutyavin et al., 2000) , one mismatch remained to gyrA of strain T2; plc transcript levels normalized against gyrA might therefore be slightly overestimated for T2 (Fig. 1B) . The log-linear range for all qPCR reactions spanned five orders of magnitude with an r 2 > 0.99 (Fig. S1 ). The regression curves for plc, gyrA, and rplL had slopes of 3.33, 3.37, and 3.32, corresponding to amplification efficiencies of 0.99, 0.98, and 1.00, respectively. The contribution of genomic DNA to the cDNA signal was assessed by determination of the DC T for the RT-qPCR with and without addition of reverse transcriptase. During exponential growth, all samples tested had a DC T > 4, indicating a contribution of genomic DNA of <10% to the cDNA signal (calculated from the slope of the regression line). This value is within experimental variation and does not interfere with the transcript quantification. In contrast, the DC T was <0.5 in late stationary phase, resulting in transcript levels below the detection limit of the assay.
3.2.1. Transcript levels of plc and production of a-toxin during growth of C. perfringens
The growth of the three different strains reached the early exponential phase and early stationary phase after 1-2 and 5-9 h, respectively (Fig. 1A) .
The plc transcription dynamics showed the same trend irrespective which transcripts (gyrA or rplL) were used for normalization (Fig. 1B and C) . Transcript levels of plc strongly differed between the three strains; for strain T2, it was just around the detection limit throughout the entire growth phase, and no toxin was detected in the culture supernatant, although low levels of a-toxin production had been observed for this strain in an earlier study (Abildgaard et al., 2009) . Strains T9 and S3 showed much higher plc transcript levels and a 4-to 30-fold increase from early to late exponential phase (Fig. 1B and C) . Although following the same dynamics, the relative transcript level of strain S3 was however up to 10 times higher than the level observed for strain T9 (Fig. 1B and C) .
Discussion
Levels of a-toxin production
The reproducibility of the levels of a-toxin accumulation measured in supernatants of the batch cultures combined with the fact that only insignificant levels of the toxin were detectable in cell lysates, support the use of secreted a-toxin as a measure of the strain-specific production pattern in accordance with previously reported observations (Abildgaard et al., 2009; Gholamiandekhordi et al., 2006) . It is however important to emphasize that comparison should only be made between strains grown under comparable conditions, since, e.g., culture media and pH have been reported to influence toxin production levels of C. perfringens significantly (Fernandez-Miyakawa et al., 2007; Mö llby et al., 1976) .
4.1.1. Transcript levels of plc and production of a-toxin during growth of C. perfringens
Comparison of Fig. 1A -C indicates that transcription of plc is induced in exponential phase rather than being constitutive. Peaking of a-toxin accumulation in exponential phase has previously been reported (Bullifent et al., 1996) , but to our knowledge, the present study is the first to demonstrate induced plc transcription in direct comparison to housekeeping genes. The expression pattern of plc could potentially reflect an evolutionary strategy to increase substrate availability in crowded environments by increasing toxin (phospholipase) production. A similar up-shift in transcription of the gene encoding botulinum neurotoxin (cntA) has been observed in Clostridium botulinum (Sharkey et al., 2005; Shin et al., 2006) . A difference in transcript levels between strains T9 and S3 by up to a factor 10 was shown in Fig. 1B and C. An earlier study using Northern hybridization of plc mRNA had also reported large variations in transcript levels between strains, up to 40-fold (Tsutsui et al., 1995) . Surprisingly, strain T9, with the lower transcript levels, produced the higher amount of a-toxin, i.e., 0.49 U ml À1 in late stationary phase vs. 0.13 U ml À1 produced by the highly plc-transcribing strain S3 (Fig. 1D) . This is in contrast to earlier findings of high correlation between plc mRNA and a-toxin levels also in strains showing different levels of phospholipase C activity (Bullifent et al., 1996) . The plc gene of strain S3 contains an 834 bp-intron (Abildgaard et al., 2009) , previously found also in other C. perfringens strains (Ma et al., 2007) , which theoretically could decrease translation efficiencies due to the need for mRNA processing (splicing). However, no un-spliced mRNA has been detected in these strains (Abildgaard et al., 2009; Ma et al., 2007) , indicating rapid mRNA processing. The most probable explanation for the discrepancy in apparent transcription and translation levels between strains T9 and S3 is therefore that both features are strain-specific.
Implications for monitoring the effect of NE treatment
Transcript levels of toxin genes have been used to monitor the efficiency of treatments against Salmonella (Lim et al., 2007) , Vibrio (Lim et al., 2007) , and C. botulinum (Sharkey et al., 2005; Shin et al., 2006) . Likewise, plc gene copy numbers and transcript levels may be used to evaluate the effect of treatments on number and a-toxin production of C. perfringens in pure cultures of known strain types. Towards that end, our revised qPCR probe/ primer set offers a reliable tool to determine a-toxin gene copy numbers and, combined with RT and normalization against gyrA or rplL mRNA, a-toxin gene transcript levels.
However, due to the putative induction of plc transcription during exponential growth, different strains need to be in the same growth phase when comparing treatment effects on plc transcript levels. Finally, it is crucial to note that according to our findings, plc gene transcript (mRNA) levels can only be used to predict the amount of a-toxin produced when knowing the degree of translational regulation for the strains in question. The protocol can be further developed to measure the effect on NE treatments on plc transcription and a-toxin production in intestinal content of broilers during challenge trials. Again for this purpose the relationship between plc transcription and a-toxin production of the strain(s) used for infection should be assessed in vitro.
Acknowledgements
The study was supported by the EC-funded FP6 project REPLACE (Food-CT-2004-506487) . The authors wish to thank K. Pedersen for supplying the strains.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in the online version, at doi:10.1016/j.vetmic. 2009.05.014.
